Investigating the Optimal Management of Dolutegravir Resistance

NCT06762054 · clinicaltrials.gov ↗

RECRUITING

Status

6600

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Continue DTG-based antiretroviral therapy
BEHAVIORAL: Enhanced adherence counselling

Sponsor

University of Nairobi

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]